诺诚健华(09969)今日盘中股价大幅上涨5.08%，市场表现强劲。
消息面上，公司此前发布的2025年年度报告显示业绩表现优异，是推动股价上涨的主要原因。报告期内，公司实现营业总收入23.75亿元，同比大幅增长135.27%；归母净利润达到6.42亿元，同比扭亏为盈，增幅高达245.81%。其中，第四季度业绩尤为亮眼，单季度归母净利润同比飙升527.84%。
此外，公司核心产品奥布替尼销量持续增长，新药坦昔妥单抗已启动商业化销售并开始贡献收入。公司2025年首次实现年度盈利，其A股股票亦因此取消特别标识。这些积极的财务和业务进展显著增强了投资者对公司未来发展的信心，从而带动了股价在交易时段内的上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.